CHI Advisors as of Sept. 30, 2021
Portfolio Holdings for CHI Advisors
CHI Advisors holds 19 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 19.8 | $68M | 2.9M | 23.71 | |
| Repare Therapeutics Ord (RPTX) | 17.1 | $59M | 2.2M | 26.24 | |
| Cullinan Oncology (CGEM) | 14.8 | $51M | 2.2M | 22.57 | |
| Pliant Therapeutics (PLRX) | 12.2 | $42M | 2.5M | 16.88 | |
| Vectivbio Hldg Ord Shs | 5.8 | $20M | 2.6M | 7.73 | |
| Omega Therapeutics Common Stock (OMGAQ) | 5.8 | $20M | 1.1M | 18.85 | |
| Larimar Therapeutics (LRMR) | 5.1 | $18M | 1.5M | 11.53 | |
| Oncorus | 4.8 | $16M | 1.8M | 9.34 | |
| Inozyme Pharma (INZY) | 3.1 | $11M | 920k | 11.59 | |
| Akouos | 2.9 | $10M | 858k | 11.61 | |
| Orchard Therapeutics Ads | 2.7 | $9.4M | 4.1M | 2.30 | |
| Precision Biosciences Ord | 2.2 | $7.5M | 647k | 11.54 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 1.4 | $4.9M | 1.4M | 3.41 | |
| Ikena Oncology (IKNA) | 1.2 | $4.0M | 315k | 12.62 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $803k | 166k | 4.84 | |
| Ovid Therapeutics (OVID) | 0.2 | $785k | 234k | 3.36 | |
| G1 Therapeutics | 0.2 | $671k | 50k | 13.42 | |
| Kezar Life Sciences | 0.2 | $648k | 75k | 8.64 | |
| Keros Therapeutics (KROS) | 0.1 | $500k | 13k | 39.60 |
